Jones Financial Companies
DAWN

Jones Financial Companies’s Day One Biopharmaceuticals DAWN Stock Holding History

Jones Financial Companies’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43 Sell
2
-1,000
-100% -$14.1K ﹤0.01% 4677
2025
Q4 		$9.34K Hold
1,002
– – ﹤0.01% 3251
2025
Q3 		$6.78K Buy
1,002
+1,000
+50,000% +$6.88K ﹤0.01% 3240
2025
Q2 		$13 Sell
2
-361
-99% -$2.48K ﹤0.01% 4007
2025
Q1 		$2.93K Buy
+363
New +$3.91K ﹤0.01% 3142

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Jones Financial Companies's DAWN Position: Q1 2026 in Review

Jones Financial Companies reduced its Day One Biopharmaceuticals (DAWN) stake by 100% in Q1 2026, selling an estimated $14.1K and leaving 2 shares worth $43. The position accounts for ﹤0.01% of the portfolio, ranked #4677.

Jones Financial Companies first reported a position in DAWN in Q1 2025 and has held it in 5 quarters since. The position peaked at $9.34K in Q4 2025. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Jones Financial Companies held 2 shares of Day One Biopharmaceuticals worth $43 as of Q1 2026.
  • Jones Financial Companies sold 1,000 Day One Biopharmaceuticals shares in Q1 2026, an estimated $14.1K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4677 holding.
  • Jones Financial Companies first reported a position in Day One Biopharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Jones Financial Companies's Day One Biopharmaceuticals position peaked at $9.34K in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.